CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Evaluation of second line art drugs in the management of hiv-2 cases attending art opd in government medicalcollege and hospital, Aurangabad

Author: 
Dr. Borkar Mangala, S., Dr. Pandey Vimlesh, R., Dr. Surwade Gajanan, S., Dr. Rewari Bharat, B., Dr. Pawar Shilpa, Y. and Dr. Varun V. Nagori
Subject Area: 
Health Sciences
Abstract: 

Background : HIV‐2 is intrinsically resistant to non-nucleoside reverse transcriptase (NNRTI) drugs, Nevirapine and Efavirenz, the mainstay of national first line ART regimen.1 Studies mention that there is no clearly accepted regime for the management of HIV‐2 . Aim of study: To study the response to second –line ART drugs (as prescribed by NACO) in the HIV‐2 cases attending ART center of tertiary care hospital. Method: It is a cross- sectional study. Of the 12906 HIV cases registered in the ART Center of this institute, 16 cases are HIV‐2 cases. In the present study, though the clinical profile of all the 16 has been reported, only 8 of the 16 who have been receiving treatment for more than a year have been studied for response to second line ART. Rise in CD 4 count, weight gain and rise in hemoglobin was calculated and statistical test of significance was applied. Results: There was significant rise in CD4 count (p value of 0.007) and significant gain in weight (p value of 0.015), while change in hemoglobin before and after therapy was not significant. Limitations: As reliable viral load measurement is not yet available for HIV‐2infection,1 the patients’ response has to be judged clinically ,by rise in CD 4 count and weight gain. Conclusion: After statistical analysis, it was observed that there was a significant rise in CD4 count and weight gain after one year of second line therapy. None of these patients developed new opportunistic infections.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran